SCEJ

$B2=3X9)3X2q(B $BBh(B86$BG/2q(B

$B9V1i?=$79~$_0lMw!J%7%s%]%8%&%`!&9V1iJ,N`JL!K(B

6) $B%7%9%F%`!&>pJs!&%7%_%e%l!<%7%g%s(B

6-b. $B%W%m%;%9%(%s%8%K%"%j%s%0(B

$B:G=*99?7F|;~!'(B2021-08-21 18:44:01

$B$3$NJ,N`$G$h$/;H$o$l(B
$B$F$$$k%-!<%o!<%I(B		$B%-!<%o!<%I(B$B
Biopharmaceuticals2$B7o(B
Chromatography2$B7o(B
Cultivation1$B7o(B

$B$BHV9f(B$B9V1iBjL\!?H/I=$B%-!<%o!<%I(B$BH/I=7A<0(B
30$B%b%N%/%m!<%J%k93BN@=B$%W%m%;%9$NE}9g@_7W$K8~$1$?:YK&G]M\$N%O%$%V%j%C%I%b%G%j%s%0(B
($BElBg1!9)(B) ($B3X(B)$B!{2,B<(B $B>?(B$B!&(B ($B3$(B)Badr Sara$B!&(B ($B@5(B)$B?y;3(B $B90OB(B		Biopharmaceuticals
Mammalian cell culture
Hybrid modeling
P
353$B%b%N%/%m!<%J%k93BN@=B$$K$*$1$k%-%c%W%A%c!
($BElBg1!9)(B) ($B3X(B)$B!{|b66(B $BK>H~(B$B!&(B ($B3$(B)Badr Sara$B!&(B ($B@5(B)$B?y;3(B $B90OB(B		Biopharmaceuticals
Robustness
Chromatography
P
532Assessment of robustness and operational considerations for the design of integrated mAb manufacturing processes.
(U. Tokyo) ($B3$(B)$B!{(BBadr Sara$B!&(B ($B3X(B)Okamura Kozue$B!&(B ($B3X(B)Takahashi Nozomi$B!&(B ($B@5(B)Sugiyama Hirokazu		Biopharmaceutical process design
Cultivation
Chromatography
O
$B9V1i?=$79~$_0lMw(B($B%7%s%]%8%&%`HV9f!&9V1iJ,N`HV9fJL(B)
$B
$B2=3X9)3X2q(B $BBh(B86$BG/2q(B
(C) 2021 $B8x1W
Most recent update: 2021-08-21 18:44:01
For more information contact $B2=3X9)3X2q(B $BBh(B86$BG/2q(B $B
E-mail: inquiry-86awww3.scej.org
This page was generated by easp 2.46; update.pl 2.37 (C)1999-2015 kawase